Merck has cut more than 200 jobs in France and sold its factories

's $1.2 billion restructuring of its manufacturing operations has taken place at a location in France where more than 200 manufacturing and research and development jobs will be stolen and sold.spokesman confirmed after French media reports that Merck was eliminating 101 of its 575 production and 106 research and development jobs at its Rio Mirabel plant, which produces and/or packages hospital and ophthalmology products.Related Information:
Merck closes plant, $
1.
2 billion in manufacturing contraction layoffsWorkers are told that research and production at the plant are steadily declining, leading Merck to consider halting production under development and finding a buyer who can deliver higher yields and sustain activity and employment on a sustainable basis., according to an emailed press release to Fierce Pharma, Merck said the process would be transparent and that "the most appropriate way to support our employees will be implemented."said last spring that it was restructuring its manufacturing operations to stop emphasizing older drugs and add biological products such as its specialized cancer warrior Keytruda and Caltex human papillomavirus vaccine Gardasil 9.:
will build
Gardasil 9
plant, adding
425,
jobs, but cutting
1 50
did not say how many plants or jobs it would spin off, but said it expected layoffs of about $1.2 billion, about 55 percent of which would be compensation costs and the rest would be accelerated depreciation of facilities to be closed or divested.same time, the company is building a new plant in Ireland that plans to hire 350 people to produce Keytruda and 425 to increase Gardasil's production in the United States. （cyy123.com）